Clinical Trial Update: Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep [Phase 2]

View source ↗

Summary

Pediatric extension study of the investigational agent NBI-827104 for epileptic encephalopathy with continuous spike-and-wave during sleep was terminated; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epileptic Encephalopathy
• Epileptic Encephalopathy with Electrical Status Epilepticus During Sleep

Drugs mentioned

• NBI-827104

Snippet

Sponsor: Neurocrine Biosciences | Conditions: Epileptic Encephalopathy, Continuous Spike and Wave During Sleep | Phase 2 | Status: TERMINATED | Results posted: 2026-02-13